Alexander Anastasios Soukas, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 17 | 2023 | 1470 | 2.850 |
Why?
|
| Caenorhabditis elegans Proteins | 11 | 2023 | 880 | 2.670 |
Why?
|
| Metformin | 5 | 2023 | 909 | 1.590 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 3 | 2023 | 170 | 1.510 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2021 | 596 | 1.040 |
Why?
|
| Mitochondrial Membranes | 3 | 2023 | 185 | 0.930 |
Why?
|
| Lysosomes | 4 | 2021 | 938 | 0.870 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2020 | 354 | 0.740 |
Why?
|
| Immediate-Early Proteins | 2 | 2021 | 444 | 0.690 |
Why?
|
| Longevity | 6 | 2023 | 1077 | 0.660 |
Why?
|
| Autophagy | 3 | 2021 | 1349 | 0.570 |
Why?
|
| Aging | 6 | 2019 | 8744 | 0.550 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2023 | 1656 | 0.540 |
Why?
|
| Antimalarials | 1 | 2023 | 909 | 0.540 |
Why?
|
| Fats | 2 | 2013 | 99 | 0.490 |
Why?
|
| Liver | 7 | 2021 | 7577 | 0.480 |
Why?
|
| Fatty Acids | 2 | 2020 | 1812 | 0.440 |
Why?
|
| Multiprotein Complexes | 3 | 2016 | 1110 | 0.430 |
Why?
|
| Lipids | 4 | 2023 | 3343 | 0.420 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2013 | 209 | 0.400 |
Why?
|
| Carrier Proteins | 3 | 2023 | 4937 | 0.390 |
Why?
|
| Organelles | 1 | 2013 | 265 | 0.380 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2018 | 2062 | 0.380 |
Why?
|
| Lipogenesis | 1 | 2012 | 217 | 0.350 |
Why?
|
| Hypoglycemic Agents | 3 | 2019 | 3109 | 0.340 |
Why?
|
| Weight Loss | 3 | 2022 | 2721 | 0.330 |
Why?
|
| Staining and Labeling | 2 | 2013 | 1081 | 0.330 |
Why?
|
| Metabolic Diseases | 3 | 2024 | 684 | 0.320 |
Why?
|
| Animals | 35 | 2024 | 169246 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2021 | 2457 | 0.320 |
Why?
|
| Mitochondria | 5 | 2023 | 3681 | 0.310 |
Why?
|
| Lipid Metabolism | 3 | 2019 | 1904 | 0.270 |
Why?
|
| Leptin | 8 | 2020 | 1599 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2023 | 12252 | 0.260 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1752 | 0.240 |
Why?
|
| Transcription Factors | 8 | 2024 | 12168 | 0.230 |
Why?
|
| Energy Metabolism | 4 | 2020 | 2907 | 0.230 |
Why?
|
| Ethyl Ethers | 1 | 2023 | 20 | 0.220 |
Why?
|
| Ethers | 1 | 2023 | 73 | 0.220 |
Why?
|
| Signal Transduction | 9 | 2023 | 23645 | 0.210 |
Why?
|
| Obesity | 5 | 2022 | 13090 | 0.210 |
Why?
|
| Trans-Activators | 1 | 2012 | 2857 | 0.200 |
Why?
|
| Adipose Tissue | 6 | 2009 | 3329 | 0.200 |
Why?
|
| Reperfusion Injury | 2 | 2019 | 1039 | 0.200 |
Why?
|
| Activins | 1 | 2024 | 211 | 0.200 |
Why?
|
| Body Size | 2 | 2016 | 463 | 0.200 |
Why?
|
| Riboflavin | 1 | 2022 | 107 | 0.200 |
Why?
|
| Insulin | 4 | 2021 | 6607 | 0.190 |
Why?
|
| Forkhead Transcription Factors | 2 | 2022 | 1625 | 0.180 |
Why?
|
| Mice, Knockout | 4 | 2021 | 14488 | 0.180 |
Why?
|
| Oxazines | 3 | 2013 | 358 | 0.180 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2019 | 35 | 0.170 |
Why?
|
| Mice, Obese | 6 | 2020 | 417 | 0.160 |
Why?
|
| Oleic Acids | 1 | 2019 | 71 | 0.160 |
Why?
|
| Hedgehog Proteins | 1 | 2023 | 771 | 0.160 |
Why?
|
| Down-Regulation | 4 | 2019 | 2937 | 0.160 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 287 | 0.160 |
Why?
|
| Oxytocin | 1 | 2022 | 404 | 0.150 |
Why?
|
| Biguanides | 1 | 2018 | 21 | 0.150 |
Why?
|
| Glucose | 3 | 2021 | 4352 | 0.150 |
Why?
|
| Candida glabrata | 1 | 2018 | 38 | 0.140 |
Why?
|
| Feeding Behavior | 2 | 2009 | 3205 | 0.140 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 2 | 2019 | 58 | 0.140 |
Why?
|
| Mice | 16 | 2024 | 82029 | 0.140 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2016 | 57 | 0.140 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2012 | 135 | 0.140 |
Why?
|
| Permeability | 1 | 2019 | 725 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 2909 | 0.140 |
Why?
|
| Candida | 1 | 2018 | 173 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2019 | 301 | 0.130 |
Why?
|
| Adipocytes | 3 | 2008 | 1197 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2021 | 8317 | 0.130 |
Why?
|
| Nuclear Pore | 1 | 2016 | 62 | 0.130 |
Why?
|
| Animals, Genetically Modified | 2 | 2019 | 1563 | 0.130 |
Why?
|
| Insulin Resistance | 3 | 2021 | 3986 | 0.130 |
Why?
|
| Gene Expression Regulation | 5 | 2014 | 11928 | 0.120 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2016 | 199 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 22379 | 0.120 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3833 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 623 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 501 | 0.120 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2015 | 225 | 0.110 |
Why?
|
| Aminoisobutyric Acids | 1 | 2014 | 39 | 0.110 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 2013 | 23 | 0.110 |
Why?
|
| Clutch Size | 1 | 2013 | 1 | 0.110 |
Why?
|
| Consensus | 1 | 2023 | 3212 | 0.110 |
Why?
|
| 2-Propanol | 1 | 2013 | 28 | 0.110 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 7608 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1143 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 9615 | 0.100 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 1145 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2018 | 761 | 0.100 |
Why?
|
| Food Deprivation | 2 | 2005 | 114 | 0.100 |
Why?
|
| Sirolimus | 1 | 2019 | 1540 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1247 | 0.100 |
Why?
|
| Germ Cells | 1 | 2015 | 644 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2012 | 378 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2019 | 1397 | 0.090 |
Why?
|
| Food | 1 | 2015 | 768 | 0.090 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 371 | 0.090 |
Why?
|
| Boron Compounds | 2 | 2009 | 196 | 0.090 |
Why?
|
| Methyltransferases | 1 | 2013 | 373 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 414 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2019 | 3080 | 0.090 |
Why?
|
| Triglycerides | 2 | 2019 | 2464 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4283 | 0.080 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2009 | 72 | 0.080 |
Why?
|
| Reproduction | 2 | 2015 | 646 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 1 | 2012 | 467 | 0.080 |
Why?
|
| Phospholipids | 1 | 2013 | 787 | 0.080 |
Why?
|
| Fixatives | 1 | 2009 | 90 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 801 | 0.080 |
Why?
|
| Oncogene Protein v-akt | 1 | 2009 | 130 | 0.080 |
Why?
|
| DNA Primers | 1 | 2013 | 2828 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 701 | 0.080 |
Why?
|
| Somatomedins | 1 | 2009 | 179 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3139 | 0.080 |
Why?
|
| Steam Bath | 1 | 1988 | 1 | 0.080 |
Why?
|
| Up-Regulation | 4 | 2019 | 4146 | 0.080 |
Why?
|
| Cholesterol | 2 | 2019 | 2914 | 0.070 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 776 | 0.070 |
Why?
|
| Adipocytes, Brown | 2 | 2020 | 160 | 0.070 |
Why?
|
| Humans | 16 | 2023 | 768166 | 0.070 |
Why?
|
| Whole Body Imaging | 1 | 2008 | 284 | 0.070 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2015 | 1399 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2005 | 3800 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 2633 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2013 | 5027 | 0.060 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2004 | 84 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 9561 | 0.060 |
Why?
|
| RNA Interference | 1 | 2013 | 2832 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2020 | 3803 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3433 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2012 | 2451 | 0.050 |
Why?
|
| Lipodystrophy | 1 | 2004 | 145 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2001 | 1084 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2005 | 1550 | 0.050 |
Why?
|
| Lipoproteins, VLDL | 2 | 2019 | 201 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2810 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18349 | 0.050 |
Why?
|
| Haptoglobins | 1 | 2002 | 165 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2022 | 485 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2024 | 628 | 0.040 |
Why?
|
| Gene Expression | 3 | 2002 | 7598 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 17140 | 0.040 |
Why?
|
| Fasting | 2 | 2019 | 1610 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2020 | 562 | 0.040 |
Why?
|
| Cell Differentiation | 4 | 2020 | 11669 | 0.040 |
Why?
|
| Biological Assay | 1 | 2021 | 628 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12795 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 3044 | 0.040 |
Why?
|
| Echinocandins | 1 | 2018 | 54 | 0.040 |
Why?
|
| Lipopeptides | 1 | 2018 | 71 | 0.040 |
Why?
|
| Drug Resistance, Fungal | 1 | 2018 | 78 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2018 | 143 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2020 | 563 | 0.040 |
Why?
|
| Fluconazole | 1 | 2018 | 156 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2000 | 461 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 615 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2019 | 493 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2014 | 1968 | 0.030 |
Why?
|
| Body Weight | 3 | 2005 | 4627 | 0.030 |
Why?
|
| Vitellogenesis | 1 | 2015 | 3 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 693 | 0.030 |
Why?
|
| Species Specificity | 1 | 2020 | 2415 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 859 | 0.030 |
Why?
|
| Oleic Acid | 1 | 2015 | 91 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2819 | 0.030 |
Why?
|
| Mammals | 1 | 2020 | 1135 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2000 | 1165 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2000 | 1191 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1988 | 4045 | 0.030 |
Why?
|
| Male | 8 | 2022 | 364719 | 0.030 |
Why?
|
| Dependovirus | 1 | 2019 | 720 | 0.030 |
Why?
|
| Mycoses | 1 | 2018 | 386 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2014 | 92 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 3711 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2000 | 2732 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2202 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2014 | 177 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2019 | 1247 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1494 | 0.030 |
Why?
|
| Base Sequence | 2 | 2019 | 12421 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 1276 | 0.020 |
Why?
|
| Female | 10 | 2022 | 397192 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2089 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 1967 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2020 | 2629 | 0.020 |
Why?
|
| Time Factors | 3 | 2005 | 40218 | 0.020 |
Why?
|
| Diet | 1 | 2009 | 8089 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 1183 | 0.020 |
Why?
|
| Adiposity | 1 | 2020 | 1895 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 3428 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4352 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2014 | 363 | 0.020 |
Why?
|
| Azo Compounds | 1 | 2009 | 116 | 0.020 |
Why?
|
| Homeostasis | 1 | 2020 | 3348 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6894 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2022 | 12465 | 0.020 |
Why?
|
| Glycogen | 1 | 2008 | 252 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15662 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 22371 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 2227 | 0.020 |
Why?
|
| Eating | 2 | 2005 | 1542 | 0.020 |
Why?
|
| Accidents | 1 | 1988 | 164 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 713 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15597 | 0.020 |
Why?
|
| Finland | 1 | 1988 | 609 | 0.020 |
Why?
|
| Mutation | 2 | 2009 | 30238 | 0.020 |
Why?
|
| Death, Sudden | 1 | 1988 | 301 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5804 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19015 | 0.010 |
Why?
|
| RNA, Messenger | 3 | 2005 | 12800 | 0.010 |
Why?
|
| Weight Gain | 1 | 2014 | 2359 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2005 | 223 | 0.010 |
Why?
|
| Placenta | 2 | 2005 | 1725 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 2005 | 352 | 0.010 |
Why?
|
| Organ Size | 1 | 2008 | 2267 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10101 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1730 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 2002 | 174 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 1887 | 0.010 |
Why?
|
| Vacuoles | 1 | 2002 | 224 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 1930 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 752 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2000 | 341 | 0.010 |
Why?
|
| Angiopoietins | 1 | 2000 | 86 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1715 | 0.010 |
Why?
|
| Algorithms | 1 | 2000 | 14164 | 0.010 |
Why?
|
| Immunity | 1 | 2005 | 1003 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2005 | 1599 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2000 | 360 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 2300 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4580 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2004 | 9538 | 0.010 |
Why?
|
| Exercise | 1 | 2014 | 5955 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 2843 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2748 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2002 | 1880 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 16726 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 65371 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3655 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6514 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2720 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4938 | 0.010 |
Why?
|
| Risk Factors | 2 | 2014 | 74944 | 0.010 |
Why?
|
| Thiazoles | 1 | 2000 | 1542 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 4978 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 13421 | 0.000 |
Why?
|
| Middle Aged | 1 | 2022 | 223492 | 0.000 |
Why?
|
| Adult | 1 | 2022 | 223646 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 17622 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2002 | 5889 | 0.000 |
Why?
|
| Pregnancy | 1 | 2000 | 30256 | 0.000 |
Why?
|